Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Interventions for fatigue in peripheral neuropathy.

White CM, van Doorn PA, Garssen MP, Stockley RC.

Cochrane Database Syst Rev. 2014 Dec 18;(12):CD008146. doi: 10.1002/14651858.CD008146.pub2. Review.

PMID:
25519471
2.

Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study.

Garssen MP, van Koningsveld R, van Doorn PA, Merkies IS, Scheltens-de Boer M, van Leusden JA, van Schaik IN, Linssen WH, Visscher F, Boon AM, Faber CG, Meulstee J, Prick MJ, van den Berg LH, Franssen H, Hiel JA, van den Bergh PY, Sindic CJ.

J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):1012-3. No abstract available. Erratum in: J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1416. Merkies, ISJ [added]; Scheltens-de Boer M [added]; van Leusden, JA [added]; van Schaik, IN [added]; Linssen, WHJP [added]; Visscher, F [added]; Boon, AM [added]; Faber, CG [added]; Meulstee, J [added]; Prick, MJJ [added]; van den Berg, LH [added]; Franssen.

4.

Contribution of central and peripheral factors to residual fatigue in Guillain-Barré syndrome.

Garssen MP, Schillings ML, Van Doorn PA, Van Engelen BG, Zwarts MJ.

Muscle Nerve. 2007 Jul;36(1):93-9.

PMID:
17238173
5.

Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome.

Garssen MP, Van Koningsveld R, Van Doorn PA.

J Neurol. 2006 Sep;253(9):1143-6. Epub 2006 Sep 22.

PMID:
16998652
6.

Nerve conduction studies in relation to residual fatigue in Guillain-Barré syndrome.

Garssen MP, van Doorn PA, Visser GH.

J Neurol. 2006 Jul;253(7):851-6. Epub 2006 Jul 17.

PMID:
16845568
7.

Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.

Garssen MP, Schmitz PI, Merkies IS, Jacobs BC, van der Meché FG, van Doorn PA.

J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):61-5.

8.

Conduction velocity distribution in neurologically well-recovered but fatigued Guillain-Barré syndrome patients.

Garssen MP, Blok JH, van Doorn PA, Visser GH.

Muscle Nerve. 2006 Feb;33(2):177-82.

PMID:
16270305
9.

Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.

Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, van Doorn PA.

Neurology. 2004 Dec 28;63(12):2393-5.

PMID:
15623709
10.

[Neuromyelitis optica (Devic's disease): a severe variant of multiple sclerosis].

Neuteboom RF, Garssen MP, Hintzen RQ.

Ned Tijdschr Geneeskd. 2004 May 29;148(22):1097-102. Dutch.

PMID:
15198064
11.

Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy.

Overeem S, Geleijns K, Garssen MP, Jacobs BC, van Doorn PA, Lammers GJ.

Neurosci Lett. 2003 Apr 24;341(1):13-6.

PMID:
12676332
12.

Treatment of immune neuropathies.

Van Doorn PA, Garssen MP.

Curr Opin Neurol. 2002 Oct;15(5):623-31. Review.

PMID:
12352007

Supplemental Content

Loading ...
Support Center